Novel KRAS mutation in an unusual tectal low-grade glioma

BMJ Case Rep. 2021 Apr 1;14(4):e242306. doi: 10.1136/bcr-2021-242306.

Authors

Sharon Wulfovich¹, Suzanne Tucker², Michael Levy³, John Ross Crawford⁴

Affiliations

¹ School of Medicine University of California San Diego Health Sciences, San Diego, California, USA.
² Rady Children's Hospital, San Diego, California, USA.
³ Neurosurgery, University of California San Diego, San Diego, California, USA.
⁴ Neurosciences and Pediatrics, University of California San Diego, La Jolla, California, USA jrcrawford@ucsd.edu.

No abstract available

Keywords: neuroimaging; neurooncology; paediatric oncology; pathology.

Publication types

Case Reports

MeSH terms

Brain Neoplasms* / diagnostic imaging
Brain Neoplasms* / genetics
Glioma* / genetics
Humans
Mutation
Proto-Oncogene Proteins p21(ras) / genetics
Tectum Mesencephali

Substances

KRAS protein, human
Proto-Oncogene Proteins p21(ras)